|
|
Microfluidic-based direct identification of virusneutralizing antibodies from comprehensive B-cell repertoires of elite controllers of infection (“μDIVA”) for a rapid anti-pandemic response
| Third-party funded project |
| Project title |
Microfluidic-based direct identification of virusneutralizing antibodies from comprehensive B-cell repertoires of elite controllers of infection (“μDIVA”) for a rapid anti-pandemic response |
| Principal Investigator(s) |
Palivan, Cornelia
Panke, Sven
|
| Co-Investigator(s) |
Palivan, Cornelia
Esslinger, Christoph
|
| Project Members |
Messmer, Daniel
|
| Organisation / Research unit |
Departement Chemie / Physikalische Chemie (Palivan) |
| Department |
Departement Chemie |
| Project start |
01.11.2020 |
| Probable end |
01.11.2021 |
| Status |
Completed |
| Abstract |
The innovative microfluidic screening platform μDIVA will allow direct discovery of neutralizing antibodies against viral infections and thus shorten the drug development process. It will be benchmarked with the current pandemic SARS-CoV-2 and applied to the discovery of CMV-neutralizing antibodies. |
| Financed by |
Innovation Promotion Agency CTI
|
| |
|
|
MCSS v5.8 PRO. 0.592 sec, queries - 0.000 sec
©Universität Basel | Impressum
|  |
|
20/04/2024
Research Database / FORSCHUNGSDATENBANK
|
